156 related articles for article (PubMed ID: 7756662)
1. Antisickling effects of 2,3-diphosphoglycerate depletion.
Poillon WN; Kim BC; Labotka RJ; Hicks CU; Kark JA
Blood; 1995 Jun; 85(11):3289-96. PubMed ID: 7756662
[TBL] [Abstract][Full Text] [Related]
2. 2,3-Diphosphoglycerate and intracellular pH as interdependent determinants of the physiologic solubility of deoxyhemoglobin S.
Poillon WN; Kim BC
Blood; 1990 Sep; 76(5):1028-36. PubMed ID: 2393711
[TBL] [Abstract][Full Text] [Related]
3. The effect of 2,3-diphosphoglycerate on the solubility of deoxyhemoglobin S.
Poillon WN; Kim BC; Welty EV; Walder JA
Arch Biochem Biophys; 1986 Sep; 249(2):301-5. PubMed ID: 3753004
[TBL] [Abstract][Full Text] [Related]
4. Effects of carbon dioxide and pH variations in vitro on blood respiratory functions, red blood cell volume, transmembrane pH gradients, and sickling in sickle cell anemia.
Ueda Y; Bookchin RM
J Lab Clin Med; 1984 Aug; 104(2):146-59. PubMed ID: 6431043
[TBL] [Abstract][Full Text] [Related]
5. Deoxygenated sickle hemoglobin. Modulation of its solubility by 2,3-diphosphoglycerate and other allosteric polyanions.
Poillon WN; Robinson MD; Kim BC
J Biol Chem; 1985 Nov; 260(26):13897-900. PubMed ID: 4055763
[TBL] [Abstract][Full Text] [Related]
6. Intracellular hemoglobin S polymerization and the clinical severity of sickle cell anemia.
Poillon WN; Kim BC; Castro O
Blood; 1998 Mar; 91(5):1777-83. PubMed ID: 9473246
[TBL] [Abstract][Full Text] [Related]
7. Erythrocyte Hb-S concentration. An important factor in the low oxygen affinity of blood in sickle cell anemia.
Seakins M; Gibbs WN; Milner PF; Bertles JF
J Clin Invest; 1973 Feb; 52(2):422-32. PubMed ID: 4683881
[TBL] [Abstract][Full Text] [Related]
8. 2,3-Diphosphoglycerate phosphatase/synthase: a potential target for elevating the diphosphoglycerate level in human red blood cells.
Yu KT; Pendley C; Herczeg T; Pendleton RG
J Pharmacol Exp Ther; 1990 Jan; 252(1):192-200. PubMed ID: 2153800
[TBL] [Abstract][Full Text] [Related]
9. Effect of 2, 3-diphosphoglycerate on the solubility of deoxy-sickle hemoglobin.
Swerdlow PH; Bryan RA; Bertles JF; Poillon WN; Magdoff-Fairchild B; Milner PF
Hemoglobin; 1977; 1(6):527-37. PubMed ID: 914634
[TBL] [Abstract][Full Text] [Related]
10. pH dependency of potassium efflux from sickled red cells.
Roth EF; Nagel RL; Bookchin RM
Am J Hematol; 1981; 11(1):19-27. PubMed ID: 6267938
[TBL] [Abstract][Full Text] [Related]
11. Antisickling effect of chrysin is associated with modulation of oxygenated and deoxygenated haemoglobin via alteration of functional chemistry and metabolic pathways of human sickle erythrocytes.
Nwankwo HC; Idowu AA; Muhammad A; Waziri AD; Abubakar YS; Bashir M; Erukainure OL
Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S108-S124. PubMed ID: 34151613
[TBL] [Abstract][Full Text] [Related]
12. Dimethyl adipimidate: a new antisickling agent.
Lubin BH; Pena V; Mentzer WC; Bymun E; Bradley TB; Packer L
Proc Natl Acad Sci U S A; 1975 Jan; 72(1):43-6. PubMed ID: 1054514
[TBL] [Abstract][Full Text] [Related]
13. Relationship between the nicotinamide adenine dinucleotide redox potential and the 2,3-diphosphoglycerate content in the erythrocyte in sickle cell disease.
Lachant NA; Zerez CR; Tanaka KR
Br J Haematol; 1989 Jun; 72(2):265-71. PubMed ID: 2757969
[TBL] [Abstract][Full Text] [Related]
14. Deoxygenation permeabilizes sickle cell anaemia red cells to magnesium and reverses its gradient in the dense cells.
Ortiz OE; Lew VL; Bookchin RM
J Physiol; 1990 Aug; 427():211-26. PubMed ID: 2213597
[TBL] [Abstract][Full Text] [Related]
15. Postnatal regulation of canine oxygen delivery: control of erythrocyte 2,3-DPG levels.
Mueggler PA; Black JA
Am J Physiol; 1982 Apr; 242(4):H500-6. PubMed ID: 6278964
[TBL] [Abstract][Full Text] [Related]
16. Effects of cyanate and 2,3-diphosphoglycerate on sickling. Relationship to oxygenation.
Jensen M; Bunn HF; Halikas G; Kan YW; Nathan DG
J Clin Invest; 1973 Oct; 52(10):2542-7. PubMed ID: 4729047
[TBL] [Abstract][Full Text] [Related]
17. Methyl acetyl phosphate, a new type of antisickling agent: site-specific acetylating agent toward the 2,3-DPG binding site in hemoglobin S.
Ueno H; Manning JM
Am J Pediatr Hematol Oncol; 1988; 10(4):348-50. PubMed ID: 3239714
[TBL] [Abstract][Full Text] [Related]
18. VZHE-039, a novel antisickling agent that prevents erythrocyte sickling under both hypoxic and anoxic conditions.
Abdulmalik O; Pagare PP; Huang B; Xu GG; Ghatge MS; Xu X; Chen Q; Anabaraonye N; Musayev FN; Omar AM; Venitz J; Zhang Y; Safo MK
Sci Rep; 2020 Nov; 10(1):20277. PubMed ID: 33219275
[TBL] [Abstract][Full Text] [Related]
19. Structural features required for the reactivity and intracellular transport of bis(3,5-dibromosalicyl)fumarate and related anti-sickling compounds that modify hemoglobin S at the 2,3-diphosphoglycerate binding site.
Chatterjee R; Iwai Y; Walder RY; Walder JA
J Biol Chem; 1984 Dec; 259(23):14863-73. PubMed ID: 6501320
[TBL] [Abstract][Full Text] [Related]
20. Phosphorus-31 nuclear magnetic resonance studies of human red blood cells.
Tehrani AY; Lam YF; Lin AK; Dosch SF; Ho C
Blood Cells; 1982; 8(2):245-61. PubMed ID: 7159749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
